We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

175 hedge funds and large institutions have $439M invested in Filana Therapeutics in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 23

60% more call options, than puts

Call options by funds: $276M | Put options by funds: $173M

57% more capital invested

Capital invested by funds: $279M → $439M (+$160M)

29% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 34

17% more funds holding

Funds holding: 149 → 175 (+26)

1.34% more ownership

Funds ownership: 24.89% → 26.23% (+1.3%)

Holders
175
Holders Change
+26
Holders Change %
+17.45%
% of All Funds
3.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
44
Reduced
34
Closed
23
Calls
$276M
Puts
$173M
Net Calls
+$103M
Net Calls Change
+$106M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$6.49M
2
Marshall Wace
Marshall Wace
United Kingdom
+$4.25M
3
Bank of America
Bank of America
North Carolina
+$3.34M
4
GC
GMT Capital
Georgia
+$3.11M
5
SC
Sculptor Capital
New York
+$2.04M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.75M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$2.49M
3
Stifel Financial
Stifel Financial
Missouri
-$2.45M
4
SG Americas Securities
SG Americas Securities
New York
-$1.25M
5
KAS
Kestra Advisory Services
Texas
-$984K
Name Holding Trade Value Shares
Change 		Change in
Stake
BL
101
Bleichroeder LP
New York
$209K – – –
Fidelity Investments
102
Fidelity Investments
Massachusetts
$207K +$118K +4,385 +769%
BRWA
103
B. Riley Wealth Advisors
Florida
$205K +$132K +4,895 New
VFA
104
Valeo Financial Advisors
Indiana
$205K +$132K +4,902 New
OQS
105
Occudo Quantitative Strategies
Florida
$205K +$133K +4,911 New
CAC
106
Cowen and Company
New York
$187K +$526K +19,467 New
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
$183K -$21.6K -798 -15%
VEA
108
Virtus ETF Advisers
New York
$178K +$702 +26 +0.6%
Federated Hermes
109
Federated Hermes
Pennsylvania
$174K +$71.1K +2,633 +172%
Wells Fargo
110
Wells Fargo
California
$150K +$34.8K +1,287 +56%
ACM
111
ACT Capital Management
Pennsylvania
$142K +$91.8K +3,400 New
PNC Financial Services Group
112
PNC Financial Services Group
Pennsylvania
$131K – – –
AIP
113
Ameritas Investment Partners
Nebraska
$125K – – –
LSA
114
Leonteq Securities AG
Switzerland
$105K – – –
Simplex Trading
115
Simplex Trading
Illinois
$101K -$293K -10,854 -82%
MLICM
116
Metropolitan Life Insurance Company (MetLife)
New York
$99.2K – – –
APA
117
American Portfolios Advisors
New York
$96.2K +$62.1K +2,300 New
BAM
118
Byrne Asset Management
New Jersey
$91K -$3.46K -128 -6%
FDCDDQ
119
Federation des caisses Desjardins du Quebec
Quebec, Canada
$89.7K – – –
Canada Life
120
Canada Life
Manitoba, Canada
$86K – – –
BCV
121
Banque Cantonale Vaudoise
Switzerland
$84K +$54K +2,000 New
SAM
122
Shell Asset Management
Netherlands
$67K -$5.75K -213 -12%
Macquarie Group
123
Macquarie Group
Australia
$61K – – –
TRCT
124
Tower Research Capital (TRC)
New York
$56K -$231K -8,553 -86%
CFGS
125
Concourse Financial Group Securities
Alabama
$56K – – –
3 4
5
6 7

FLNA Hedge Fund Activity: Q3 2022 in Review

175 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2022, worth a combined $439M — up 57% from $279M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new FLNA positions and 23 closed out — a net gain of 26 holders — while 44 added to existing stakes and 34 trimmed.

The largest buyer was Invesco, adding an estimated $6.49M. The largest seller was BlackRock, cutting an estimated $4.75M.

  • 175 institutional investors held Filana Therapeutics (FLNA) as of Q3 2022, up from 149 in Q2 2022.
  • Funds reported $439M of Filana Therapeutics stock for Q3 2022, up 57% quarter-over-quarter.
  • 49 funds opened new Filana Therapeutics positions in Q3 2022 and 23 closed out, a net change of +26 holders.
  • The largest Filana Therapeutics buyer in Q3 2022 was Invesco, an estimated $6.49M added.
  • The largest Filana Therapeutics seller in Q3 2022 was BlackRock, an estimated $4.75M sold.

Based on aggregated 13F filings for Q3 2022.